Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Rao M.P.; Halvorsen, S; Wojdyla D.; Thomas L.; Alexander, JH; Hanna M.; Bahit M.C.; De Caterina R.; Erol, C; Goto S.; Lanas F.; Lewis B.S.; Husted, S.; Gersh, BJ; Wallentin L.; et. al.

Keywords: stroke, atrial fibrillation, apixaban, blood pressure control, systemic embolism

Más información

Título según WOS: Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Título según SCOPUS: Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: Results from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial
Título de la Revista: Journal of the American Heart Association
Volumen: 4
Número: 12
Editorial: American Heart Association Inc.
Fecha de publicación: 2015
Idioma: English
DOI:

10.1161/JAHA.115.002015

Notas: ISI, SCOPUS